Johnson & Johnson
Johnson & Johnson (JNJ) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · JNJ · as of Jun 8, 2026
Key Statistics
Explore Johnson & Johnson Data
jnj stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 40 · Buy rate: 52.5%
The JNJ analyst consensus is Buy, based on ratings from 40 Wall Street analysts over the past 3 months. The average 12-month price target is $250.58, representing +7.65% upside from the current price of $232.77.
Competitors & Peers
jnj competitorsJNJ
ABBV
AMGN
AZN
GILD
MRKStock Performance
Full HistoryAbout Johnson & Johnson
Johnson & Johnson together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health …
what is johnson & johnson · jnj stock overview · johnson & johnson company profile · who is johnson & johnson ceo · jnj NYSE · johnson & johnson headquarters · johnson & johnson business segments
About Stock Overview & Key Data
Johnson & Johnson (JNJ) is a Healthcare company in the Drug Manufacturers - General industry, listed on NYSE since Jan 2, 1943. As of the latest trading session, JNJ stock price is $232.77, with a market capitalization of $560.3B. The stock has returned +49.95% over the past 12 months and +12.48% year-to-date.
According to 40 Wall Street analysts, the consensus rating for Johnson & Johnson stock is Buy, with an average 12-month price target of $250.58. In fiscal year 2025, Johnson & Johnson reported revenue of $94.2B and net income of $26.8B. For detailed data — including Johnson & Johnson revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Johnson & Johnson (JNJ) stock price is $232.77. The stock is traded on NYSE under the ticker symbol JNJ. The 52-week range is $149.04 – $251.71.